Clinical Trial Update: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

View source ↗

Summary

Expanded-access study of melphalan with the Delcath CS-PHP system for liver metastases from ocular or cutaneous melanoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Liver Cancer
• Ocular Melanoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Delcath Systems Inc. | Conditions: Metastatic Liver Cancer, Ocular Melanoma | Status: NO_LONGER_AVAILABLE